Novartis to review $600m global media business

Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated $600m global media business.

Novartis: calls global media review
Novartis: calls global media review

WPP's MEC is the incumbent on the global business, including in the UK.

In 2008 Novartis consolidated its US media planning and buying into MEC after moving its business from sibling agency Mindshare in a global realignment.

The company, which has a consumer health business that markets over the counter medicines such as Tixylix and Savlon, spent £9m in the UK in the past 12 months, according to Nielsen.

Novartis, which is headquartered in Basel, Switzerland, has three other businesses called Pharmaceuticals, Vaccines and Diagnostics, and Sandoz Generics, a global supplier of generic medicines that are produced after a popular medicine's patent has expired.

Have your say...

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus
Media Week Jobs
Search for more media jobs

Latest

Yahoo appoints Marc Bignell as head of trading for the EMEA region

Yahoo appoints Marc Bignell as head of trading for the EMEA region

Yahoo has confirmed the appointment of Omnicom's Marc Bignell as head of trading across Europe, Middle East and Africa.

Share
Mail Online ads up 49% to generate third of Daily Mail's ad revenues

Mail Online ads up 49% to generate third of Daily Mail's ad revenues

Growth in digital ad revenues at Mail Online more than offset falls at the Daily Mail and Mail on Sunday newspapers in the last quarter, generating a third of the newsbrand's ad revenues at £15m.

Share
Make an emotional impact
[Sponsored feature]
Share

Get news by email